AB Science S.A.

Biotechnology · PARIS, I0

BiotechnologySEC Form D

AB Science S.A. filed a Form D with the U.S. Securities and Exchange Commission on May 18, 2026, reporting $2,989,368 raised.

Incorporated in France and based in PARIS, I0, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that AB Science S.A. has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Alain MoussyExecutive Officer · Director
  • Laurent GuyExecutive Officer
  • Christian FassotteExecutive Officer
  • Alexis BernardExecutive Officer
  • Patrick MoussyDirector
  • Jean-Pierre KinetDirector
  • Brigitte ReverdinDirector
  • Nathalie RiezDirector
  • Emmanuelle MoureyDirector
  • Beatrice BihrDirector

Recently funded in Biotechnology

Other companies that recently filed a Form D

$3.2MRaised

Goldenrod Therapeutics, Inc.

BiotechnologyHOUSTON, TX
May 26, 2026View SEC Form D
$10.0MRaised

Human Biotech, Inc.

BiotechnologyCAMBRIDGE, MA
May 22, 2026View SEC Form D
$1.0MRaised

Optimeos Life Sciences, Inc.

BiotechnologyPRINCETON, NJ
May 22, 2026View SEC Form D
$2.5MRaised

BioStem Technologies, Inc.

BiotechnologyPOMPANO BEACH, FL
May 21, 2026View SEC Form D
$10.0MRaised

Senti Biosciences Holdings, Inc.

BiotechnologySouth San Francisco, CA
May 20, 2026View SEC Form D
AB Science S.A. raised $3.0M — SEC Form D